Functional assessment of cancer therapy (FACT-G): Non-response to individual questions

Quality of Life Research

Volumn 5, Issue 3, 1996, Pages 321-329

  Fairclough, D L ^a,b   Cella, D F ^c  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Imputation; Missing data; Non response; Quality of life

Indexed keywords

ADULT; AGED; ARTICLE; BIOSTATISTICS; CANCER THERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FUNCTIONAL ASSESSMENT; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE;

ACTIVITIES OF DAILY LIVING; ADAPTATION, PSYCHOLOGICAL; ADULT; AGED; AGED, 80 AND OVER; BIAS (EPIDEMIOLOGY); CLINICAL TRIALS; DATA COLLECTION; FACTOR ANALYSIS, STATISTICAL; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PSYCHOLOGICAL TESTS; PSYCHOMETRICS; QUALITY OF LIFE; REPRODUCIBILITY OF RESULTS; SICK ROLE;

EID: 0030015311     PISSN: 09629343     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00433916     Document Type: Article

References (15)

1. Korn EL, O'Fallon J. Statistical Considerations, Statistics Working Group. Quality of Life Assessment in Cancer Clinical Trials. Report on the Workshop on Quality of Life Research in Cancer Clinical Trials, Division of Cancer Prevention and Control. National Cancer Institute, 1990.
2. Fairclough DL, Gelber RD. Quality of Life: Statistical Issues and Analysis. Quality of Life and Pharmacoeconomics in Clinical Trials, Second Edition. Spilker B, ed. New York: Raven Press Ltd, 1995.
3. Hopwood P, Stephens RJ, Machin D. Approaches to the analysis of quality of life data: experiences gained from a Medical Research Council Lung Cancer Working Party palliative chemotherapy trial. Qual Life Res 1994; 3: 339-352.
4. Dempster AP, Laird NM, Rubin DB. Maximum likelihood from incomplete data via the EM algorithm (with Discussion). J R Stat Soc B 1972; 39: 1-38.
5. Jennrich R, Schluchter M. Unbalanced repeated-measures models with structured covariance matrices. Biometrics 1986; 42: 805-820.
6. Schluchter MD. Methods for the analysis of informatively censored Longitudinal data. Statistics in Medicine 1992; 11: 1861-1870.
7. DeGruttola V, Tu XM. Modeling progression of CD4-Lymphocyte counts and its relationship to survival time. Biometrics 1994; 50: 1003-1014.
8. Little RJ, Rubin DB. Statistical Analysis with Missing Data. New York: John Wiley & Sons, 1987.
9. Morris J, Coyle D. Quality of life questionnaires in cancer clinical trials: Imputing missing values. Psycho-Oncology 1994; 3: 215-222.
10. Cella DF, Tulsky DS, Gray G, et al. The functional assessment of cancer therapy scale: Development and validation of the general measure. J Clin Oncol 1993; 11: 570-579.
11. Stewart AL, Hays RD, Ware JG. The MOS Short-form General Health Survey. Med Care 1989; 26: 724-735.
12. Schipper H, Clinch J, McMurray A, Levit M. Measuring the quality of life of cancer patients: the Functional Living Index - Cancer: Development and validation. J Clin Oncol 1984; 2: 472-483.
13. Cella DF. FACT: Manual Functional Assessment of Cancer Therapy (FACT) Scales and the Functional Assessment of HIV (FAHI) Scale. Version 3. Chicago, IL: Rush-Presbyterian-St Luke's Medical Center, 1994.
14. Ware J, Snow K, Kosinski M, Gandek B. SF-36 Health Survey: Manual and Interpretation Guide. Boston: Nimrod Press, 1993.
15. Buck SF. A method of estimation of missing values in multivariate data suitable for use with an electronic computer. J Roy Statist Soc B 1960; 22: 302-306.